Uk Biobank Material Transfer Agreement

SBP Material Transfer Agreement (MTA) Models provide for the transfer and use of biological materials or biological resources (i.e. biological materials and associated data) provided by a supplier to a non-profit third party wishing to use this material for research purposes. The models will be used by swiss Biobanking Platform (SBP) partners who adhere to the principles of governance of current ethical and legal requirements and comply with professional biobanking standards as set out in their biobanking regulations. Their use is limited to exchanges between academic institutions and is not suitable for exchanges between for-profit organizations. While sharing human biological material among cooperating researchers around the world is important for scientific progress, it is not without ethical and legal challenges. Recently, the Sanger Institute, a well-known genome research centre in the United Kingdom, caused a stir on accusations that it marketed a genetic chip without marketing a genchip with suppliers of human biological material used for the development of the genetic chip – African universities – or with donors of human biological material. African researchers (Stokstad). , 2019). One of these universities, the University of Stellenbosch in South Africa, asked Sanger to return samples (Stokstad, 2019). This incident demonstrates the sensitivity of the international transfer of human biological material and highlights the need for fair and well-developed material transfer agreements (MMAs). How can these teachings be translated into the world of bilateral and institutional material transfers? Promoting the exchange of materials towards standardized and simple concepts is an important first step.

The real challenge is to find a way to implement these lessons in order to integrate simplicity more broadly into entity to entity MTAs. Exchange through biobank intermediaries is also made more difficult by the fact that participants can accept not only individual research projects using their equipment (as is generally the case), but more generally uses that fall within the general objective for which the biobank was created. Access to biobank resources (such as the UK BioBank and other similar agreements) for research purposes therefore requires careful management that goes beyond the terms of generic MTAs. Another area of particular concern is the exchange of non-human materials from natural resources, for which the sharing of benefits is of the utmost importance.

Kontaktujte mě
Zpět na začátek